Tumor hypoxia, p53, and prognosis in cervical cancers
- 1 July 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 50 (4) , 865-872
- https://doi.org/10.1016/s0360-3016(01)01523-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapyOncogene, 1999
- Growth Inhibition of Cervical Tumor Cells by Antisense Oligodeoxynucleotides Directed to the Human Papillomavirus Type 16 E6 GeneAntisense and Nucleic Acid Drug Development, 1999
- Aberrant Expression of the Cell Cycle Associated Proteins TP53, MDM2, p21, p27, cdk4, Cyclin D1, RB, and EGFR in Cervical CarcinomasGynecologic Oncology, 1999
- Cancer Therapy and Tumor PhysiologyScience, 1998
- Hypoxia-Induced Apoptosis in Human Cells with Normal p53 Status and Function, without Any Alteration in the Nuclear Protein LevelExperimental Cell Research, 1997
- Immunohistochemical Detection of p53 and bcl-2 Proteins in Neoplastic and Non-Neoplastic Endocervical Glandular LesionsInternational Journal of Gynecological Pathology, 1997
- Prognostic Significance of Immunohistochemically Detected p53 Protein Expression in Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix Treated with Radiation Therapy AloneGynecologic Oncology, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- DNA Content as Prognostic Factor in Cervix Carcinoma Stage IB-III Treated with RadiotherapyGynecologic Oncology, 1994
- The Role of DNA Index as a Prognostic Factor in Early Cervical CarcinomaGynecologic Oncology, 1993